These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 32035124)

  • 1. Protocol paper: Stepped wedge cluster randomized trial translating the ABCS into optimizing cardiovascular care for people living with HIV.
    Williams SK; Johnson BA; Tobin JN; Luque AE; Sanders M; Carroll JK; Cassells A; Holder T; Fiscella K
    Prog Cardiovasc Dis; 2020; 63(2):125-133. PubMed ID: 32035124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reducing cardiovascular risk among people living with HIV: Rationale and design of the INcreasing Statin Prescribing in HIV Behavioral Economics REsearch (INSPIRE) randomized controlled trial.
    Takada S; Ober AJ; Currier JS; Goldstein NJ; Horwich TB; Mittman BS; Shu SB; Tseng CH; Vijayan T; Wali S; Cunningham WE; Ladapo JA
    Prog Cardiovasc Dis; 2020; 63(2):109-117. PubMed ID: 32084445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention as treatment: A bold vision for improving the cardiovascular health of people living with HIV.
    Longenecker CT; Webel AR; Lloyd-Jones DM
    Prog Cardiovasc Dis; 2020; 63(2):77-78. PubMed ID: 32088350
    [No Abstract]   [Full Text] [Related]  

  • 4. Enhancing patient and organizational readiness for cardiovascular risk reduction among Black and Latinx patients living with HIV: Study protocol.
    Hamilton AB; Brown A; Loeb T; Chin D; Grills C; Cooley-Strickland M; Liu HH; Wyatt GE
    Prog Cardiovasc Dis; 2020; 63(2):101-108. PubMed ID: 32109483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receipt and predictors of smoking cessation pharmacotherapy among veterans with and without HIV.
    Shahrir S; Crothers K; McGinnis KA; Chan KCG; Baeten JM; Wilson SM; Butt AA; Pisani MA; Baldassarri SR; Justice A; Williams EC
    Prog Cardiovasc Dis; 2020; 63(2):118-124. PubMed ID: 31987807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rationale and design of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE).
    Grinspoon SK; Fitch KV; Overton ET; Fichtenbaum CJ; Zanni MV; Aberg JA; Malvestutto C; Lu MT; Currier JS; Sponseller CA; Waclawiw M; Alston-Smith B; Cooper-Arnold K; Klingman KL; Desvigne-Nickens P; Hoffmann U; Ribaudo HJ; Douglas PS;
    Am Heart J; 2019 Jun; 212():23-35. PubMed ID: 30928825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ImPlementation REsearCh to DEvelop Interventions for People Living with HIV (the PRECluDE consortium): Combatting chronic disease comorbidities in HIV populations through implementation research.
    Gamble-George JC; Longenecker CT; Webel AR; Au DH; Brown AF; Bosworth H; Crothers K; Cunningham WE; Fiscella KA; Hamilton AB; Helfrich CD; Ladapo JA; Luque A; Tobin JN; Wyatt GE;
    Prog Cardiovasc Dis; 2020; 63(2):79-91. PubMed ID: 32199901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of a human-centered design approach to adapt a nurse-led cardiovascular disease prevention intervention in HIV clinics.
    Aifah A; Okeke NL; Rentrope CR; Schexnayder J; Bloomfield GS; Bosworth H; Grover K; Hileman CO; Muiruri C; Oakes M; Webel AR; Longenecker CT; Vedanthan R
    Prog Cardiovasc Dis; 2020; 63(2):92-100. PubMed ID: 32092444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of cardiovascular disease among people living with HIV in sub-Saharan Africa.
    Okello S; Amir A; Bloomfield GS; Kentoffio K; Lugobe HM; Reynolds Z; Magodoro IM; North CM; Okello E; Peck R; Siedner MJ
    Prog Cardiovasc Dis; 2020; 63(2):149-159. PubMed ID: 32035126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A clinician's guide to the ABCs of cardiovascular disease prevention: the Johns Hopkins Ciccarone Center for the Prevention of Heart Disease and American College of Cardiology Cardiosource Approach to the Million Hearts Initiative.
    Hsu S; Ton VK; Dominique Ashen M; Martin SS; Gluckman TJ; Kohli P; Sisson SD; Blumenthal RS; Blaha MJ
    Clin Cardiol; 2013 Jul; 36(7):383-93. PubMed ID: 23670948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular risk prediction in HIV-infected patients: comparing the Framingham, atherosclerotic cardiovascular disease risk score (ASCVD), Systematic Coronary Risk Evaluation for the Netherlands (SCORE-NL) and Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) risk prediction models.
    Krikke M; Hoogeveen RC; Hoepelman AI; Visseren FL; Arends JE
    HIV Med; 2016 Apr; 17(4):289-97. PubMed ID: 26268806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physical activity and exercise to improve cardiovascular health for adults living with HIV.
    Ozemek C; Erlandson KM; Jankowski CM
    Prog Cardiovasc Dis; 2020; 63(2):178-183. PubMed ID: 32014512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physical activity trends and metabolic health outcomes in people living with HIV in the US, 2008-2015.
    Willig AL; Webel AR; Westfall AO; Levitan EB; Crane HM; Buford TW; Burkholder GA; Willig JH; Blashill AJ; Moore RD; Mathews WC; Zinski A; Muhammad J; Geng EH; Napravnik S; Eron JJ; Rodriguez B; Bamman MM; Overton ET
    Prog Cardiovasc Dis; 2020; 63(2):170-177. PubMed ID: 32059838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disseminating, implementing, and evaluating patient-centered outcomes to improve cardiovascular care using a stepped-wedge design: healthy hearts for Oklahoma.
    Chou AF; Homco JB; Nagykaldi Z; Mold JW; Daniel Duffy F; Crawford S; Stoner JA
    BMC Health Serv Res; 2018 Jun; 18(1):404. PubMed ID: 29866120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of cardiovascular disease for historically marginalized racial and ethnic groups living with HIV: A narrative review of the literature.
    Muiruri C; Longenecker CT; Meissner EG; Okeke NL; Pettit AC; Thomas K; Velazquez E; Bloomfield GS
    Prog Cardiovasc Dis; 2020; 63(2):142-148. PubMed ID: 32057785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of stroke in people living with HIV.
    Nguyen I; Kim AS; Chow FC
    Prog Cardiovasc Dis; 2020; 63(2):160-169. PubMed ID: 32014514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic Review for the 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
    Wilson PWF; Polonsky TS; Miedema MD; Khera A; Kosinski AS; Kuvin JT
    Circulation; 2019 Jun; 139(25):e1144-e1161. PubMed ID: 30586775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV Infection and Primary Prevention of Cardiovascular Disease: Lights and Shadows in the HAART Era.
    Ballocca F; Gili S; D'Ascenzo F; Marra WG; Cannillo M; Calcagno A; Bonora S; Flammer A; Coppola J; Moretti C; Gaita F
    Prog Cardiovasc Dis; 2016; 58(5):565-76. PubMed ID: 26943980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology, pathophysiology, and prevention of heart failure in people with HIV.
    Sinha A; Feinstein M
    Prog Cardiovasc Dis; 2020; 63(2):134-141. PubMed ID: 31987806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testing the use of practice facilitation in a cluster randomized stepped-wedge design trial to improve adherence to cardiovascular disease prevention guidelines: HealthyHearts NYC.
    Shelley DR; Ogedegbe G; Anane S; Wu WY; Goldfeld K; Gold HT; Kaplan S; Berry C
    Implement Sci; 2016 Jul; 11(1):88. PubMed ID: 27377404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.